{"table":{"table":{"columns":[{"index":0,"name":"col0","values":["Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus","Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 Diabetes","Study of Pegylated Human Recombinant Arginase for Liver Cancer","Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor","Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer","Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma","Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma","Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL","Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control","Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes","The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy","A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes","Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.","Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)","A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma","Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA","A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise","Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes","Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin","Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes"]},{"index":1,"name":"col1","values":["166","457","15","249","141","166","9349","60","689","2454","435","599","1201","544","55","250","1186","881","407","397"]},{"index":2,"name":"col2","values":["Puerto Rico","Puerto Rico","Hong Kong","Puerto Rico","Puerto Rico","Puerto Rico","Puerto Rico","Puerto Rico","Hong Kong","Hong Kong","Puerto Rico","Puerto Rico","Hong Kong","Hong Kong","Hong Kong","Puerto Rico","Puerto Rico","Puerto Rico","Puerto Rico","Puerto Rico"]},{"index":3,"name":"col3","values":["metformin","metformin","doxorubicin","doxorubicin","doxorubicin","doxorubicin","doxorubicin","doxorubicin","metformin","metformin","metformin","metformin","metformin","doxorubicin","doxorubicin","antibiotic","metformin","metformin","metformin","metformin"]},{"index":4,"name":"col4","values":["2010-02-01","2010-06-01","2009-08-01","2016-12-31","2015-09-01","2012-03-01","2019-03-31","2010-11-01","2013-03-01","2014-03-01","2013-10-23","2013-11-01","2017-04-10","2021-09-30","2020-06-30","2012-09-01","2014-12-02","2015-01-22","2015-06-15","2015-11-21"]}],"table_id":"FVRBAOU9","version":"2"},"context":{"page_title":null,"page_url":null,"page_qnode":null},"links":[[[{"start":0,"end":129,"url":"http://www.wikidata.org/entity/Q64679115","qnode_id":"Q64679115"}],[],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q1183","qnode_id":"Q1183"}],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q19484","qnode_id":"Q19484"}],[]],[[{"start":0,"end":104,"url":"http://www.wikidata.org/entity/Q64675464","qnode_id":"Q64675464"}],[],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q1183","qnode_id":"Q1183"}],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q19484","qnode_id":"Q19484"}],[]],[[{"start":0,"end":62,"url":"http://www.wikidata.org/entity/Q64661921","qnode_id":"Q64661921"}],[],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q8646","qnode_id":"Q8646"}],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q18936","qnode_id":"Q18936"}],[]],[[{"start":0,"end":80,"url":"http://www.wikidata.org/entity/Q64665472","qnode_id":"Q64665472"}],[],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q1183","qnode_id":"Q1183"}],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q18936","qnode_id":"Q18936"}],[]],[[{"start":0,"end":187,"url":"http://www.wikidata.org/entity/Q64660363","qnode_id":"Q64660363"}],[],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q1183","qnode_id":"Q1183"}],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q18936","qnode_id":"Q18936"}],[]],[[{"start":0,"end":111,"url":"http://www.wikidata.org/entity/Q64659803","qnode_id":"Q64659803"}],[],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q1183","qnode_id":"Q1183"}],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q18936","qnode_id":"Q18936"}],[]],[[{"start":0,"end":164,"url":"http://www.wikidata.org/entity/Q64652731","qnode_id":"Q64652731"}],[],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q1183","qnode_id":"Q1183"}],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q18936","qnode_id":"Q18936"}],[]],[[{"start":0,"end":94,"url":"http://www.wikidata.org/entity/Q64647103","qnode_id":"Q64647103"}],[],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q1183","qnode_id":"Q1183"}],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q18936","qnode_id":"Q18936"}],[]],[[{"start":0,"end":134,"url":"http://www.wikidata.org/entity/Q64647714","qnode_id":"Q64647714"}],[],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q8646","qnode_id":"Q8646"}],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q19484","qnode_id":"Q19484"}],[]],[[{"start":0,"end":116,"url":"http://www.wikidata.org/entity/Q64647563","qnode_id":"Q64647563"}],[],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q8646","qnode_id":"Q8646"}],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q19484","qnode_id":"Q19484"}],[]],[[{"start":0,"end":193,"url":"http://www.wikidata.org/entity/Q64644833","qnode_id":"Q64644833"}],[],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q1183","qnode_id":"Q1183"}],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q19484","qnode_id":"Q19484"}],[]],[[{"start":0,"end":79,"url":"http://www.wikidata.org/entity/Q64644409","qnode_id":"Q64644409"}],[],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q1183","qnode_id":"Q1183"}],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q19484","qnode_id":"Q19484"}],[]],[[{"start":0,"end":110,"url":"http://www.wikidata.org/entity/Q66407730","qnode_id":"Q66407730"}],[],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q8646","qnode_id":"Q8646"}],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q19484","qnode_id":"Q19484"}],[]],[[{"start":0,"end":118,"url":"http://www.wikidata.org/entity/Q66411175","qnode_id":"Q66411175"}],[],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q8646","qnode_id":"Q8646"}],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q18936","qnode_id":"Q18936"}],[]],[[{"start":0,"end":152,"url":"http://www.wikidata.org/entity/Q66077685","qnode_id":"Q66077685"}],[],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q8646","qnode_id":"Q8646"}],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q18936","qnode_id":"Q18936"}],[]],[[{"start":0,"end":77,"url":"http://www.wikidata.org/entity/Q63322487","qnode_id":"Q63322487"}],[],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q1183","qnode_id":"Q1183"}],[{"start":0,"end":10,"url":"http://www.wikidata.org/entity/Q12187","qnode_id":"Q12187"}],[]],[[{"start":0,"end":225,"url":"http://www.wikidata.org/entity/Q64626358","qnode_id":"Q64626358"}],[],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q1183","qnode_id":"Q1183"}],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q19484","qnode_id":"Q19484"}],[]],[[{"start":0,"end":137,"url":"http://www.wikidata.org/entity/Q64625261","qnode_id":"Q64625261"}],[],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q1183","qnode_id":"Q1183"}],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q19484","qnode_id":"Q19484"}],[]],[[{"start":0,"end":167,"url":"http://www.wikidata.org/entity/Q64622566","qnode_id":"Q64622566"}],[],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q1183","qnode_id":"Q1183"}],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q19484","qnode_id":"Q19484"}],[]],[[{"start":0,"end":174,"url":"http://www.wikidata.org/entity/Q64598494","qnode_id":"Q64598494"}],[],[{"start":0,"end":11,"url":"http://www.wikidata.org/entity/Q1183","qnode_id":"Q1183"}],[{"start":0,"end":9,"url":"http://www.wikidata.org/entity/Q19484","qnode_id":"Q19484"}],[]]],"version":"1"},"semantic_models":[{"version":1,"nodes":[{"id":"col-0","col_index":0,"label":"col0"},{"id":"http://www.wikidata.org/entity/Q30612:0","abs_uri":"http://www.wikidata.org/entity/Q30612","rel_uri":"wd:Q30612","approximation":false,"readable_label":"clinical trial (Q30612)"},{"id":"col-3","col_index":3,"label":"col3"},{"id":"http://www.wikidata.org/entity/Q12140:0","abs_uri":"http://www.wikidata.org/entity/Q12140","rel_uri":"wd:Q12140","approximation":false,"readable_label":"medication (Q12140)"},{"id":"col-2","col_index":2,"label":"col2"},{"id":"col-1","col_index":1,"label":"col1"},{"id":"col-4","col_index":4,"label":"col4"}],"edges":[{"source":"http://www.wikidata.org/entity/Q30612:0","target":"col-0","abs_uri":"http://www.w3.org/2000/01/rdf-schema#label","rel_uri":"rdfs:label","approximation":false,"readable_label":null,"id":1},{"source":"http://www.wikidata.org/entity/Q30612:0","target":"col-2","abs_uri":"http://www.wikidata.org/prop/P131","rel_uri":"p:P131","approximation":false,"readable_label":"located in the administrative territorial entity (P131)","id":2},{"source":"http://www.wikidata.org/entity/Q30612:0","target":"http://www.wikidata.org/entity/Q12140:0","abs_uri":"http://www.wikidata.org/prop/P4844","rel_uri":"p:P4844","approximation":false,"readable_label":"research intervention (P4844)","id":3},{"source":"http://www.wikidata.org/entity/Q30612:0","target":"col-1","abs_uri":"http://www.wikidata.org/prop/P1132","rel_uri":"p:P1132","approximation":false,"readable_label":"number of participants (P1132)","id":4},{"source":"http://www.wikidata.org/entity/Q30612:0","target":"col-4","abs_uri":"http://www.wikidata.org/prop/P582","rel_uri":"p:P582","approximation":false,"readable_label":"end time (P582)","id":5},{"source":"http://www.wikidata.org/entity/Q12140:0","target":"col-3","abs_uri":"http://www.w3.org/2000/01/rdf-schema#label","rel_uri":"rdfs:label","approximation":false,"readable_label":null,"id":6}]}]}